Sanofi India Statistics
Total Valuation
Sanofi India has a market cap or net worth of INR 141.01 billion. The enterprise value is 138.75 billion.
Market Cap | 141.01B |
Enterprise Value | 138.75B |
Important Dates
The next estimated earnings date is Friday, February 21, 2025.
Earnings Date | Feb 21, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.00% |
Shares Change (QoQ) | +0.00% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 9.08M |
Valuation Ratios
The trailing PE ratio is 30.67.
PE Ratio | 30.67 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 20.65 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 30.18 |
EV / Sales | 4.92 |
EV / EBITDA | 17.54 |
EV / EBIT | 18.44 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.03 |
Debt / EBITDA | 0.03 |
Debt / FCF | n/a |
Interest Coverage | 501.67 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 64.85% |
Revenue Per Employee | 12.98M |
Profits Per Employee | 2.11M |
Employee Count | 2,174 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +53.20% in the last 52 weeks. The beta is 0.30, so Sanofi India's price volatility has been lower than the market average.
Beta (5Y) | 0.30 |
52-Week Price Change | +53.20% |
50-Day Moving Average | 6,392.22 |
200-Day Moving Average | 5,848.30 |
Relative Strength Index (RSI) | 40.50 |
Average Volume (20 Days) | 12,627 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi India had revenue of INR 28.23 billion and earned 4.60 billion in profits. Earnings per share was 199.60.
Revenue | 28.23B |
Gross Profit | 16.09B |
Operating Income | 7.53B |
Pretax Income | 7.26B |
Net Income | 4.60B |
EBITDA | 7.83B |
EBIT | 7.53B |
Earnings Per Share (EPS) | 199.60 |
Balance Sheet
The company has 2.48 billion in cash and 221.00 million in debt, giving a net cash position of 2.26 billion.
Cash & Cash Equivalents | 2.48B |
Total Debt | 221.00M |
Net Cash | 2.26B |
Net Cash Per Share | n/a |
Equity (Book Value) | 6.85B |
Book Value Per Share | 297.26 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 56.99%, with operating and profit margins of 26.66% and 16.29%.
Gross Margin | 56.99% |
Operating Margin | 26.66% |
Pretax Margin | 25.70% |
Profit Margin | 16.29% |
EBITDA Margin | 27.73% |
EBIT Margin | 26.66% |
FCF Margin | n/a |
Dividends & Yields
Sanofi India does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.00% |
Shareholder Yield | -0.00% |
Earnings Yield | 3.25% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |